The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2022 | Key genetic changes that elicit the transformation of plasma cells in myeloma
Adam Sperling, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses key genetic changes that elicit the transformation of plasma cells and influence disease progression in multiple myeloma, and the importance of further investigating these processes. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
